Literature DB >> 31477815

Targeting neuroinflammation with brain penetrant P2X7 antagonists as novel therapeutics for neuropsychiatric disorders.

Anindya Bhattacharya1, Marc Ceusters2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31477815      PMCID： PMC6879571          DOI： 10.1038/s41386-019-0502-9

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  9 in total

Review 1.  Hyperinflammation and airway surface liquid dehydration in cystic fibrosis: purinergic system as therapeutic target.

Authors:  Thiago Inácio Teixeira do Carmo; Victor Emanuel Miranda Soares; Jonatha Wruck; Fernanda Dos Anjos; Débora Tavares de Resende E Silva; Sarah Franco Vieira de Oliveira Maciel; Margarete Dulce Bagatini
Journal:  Inflamm Res       Date:  2021-04-27       Impact factor: 4.575

2.  Investigational Drugs for the Treatment of Depression (Part 2): Glutamatergic, Cholinergic, Sestrin Modulators, and Other Agents.

Authors:  Octavian Vasiliu
Journal:  Front Pharmacol       Date:  2022-06-17       Impact factor: 5.988

3.  Agonists, Antagonists, and Modulators of P2X7 Receptors.

Authors:  Christa E Müller; Vigneshwaran Namasivayam
Journal:  Methods Mol Biol       Date:  2022

Review 4.  To Inhibit or Enhance? Is There a Benefit to Positive Allosteric Modulation of P2X Receptors?

Authors:  Leanne Stokes; Stefan Bidula; Lučka Bibič; Elizabeth Allum
Journal:  Front Pharmacol       Date:  2020-05-12       Impact factor: 5.810

Review 5.  Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success.

Authors:  Max J M Silvis; Selma E Kaffka Genaamd Dengler; Clémence A Odille; Mudit Mishra; Niels P van der Kaaij; Pieter A Doevendans; Joost P G Sluijter; Dominique P V de Kleijn; Saskia C A de Jager; Lena Bosch; Gerardus P J van Hout
Journal:  Front Immunol       Date:  2020-12-08       Impact factor: 7.561

Review 6.  Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor.

Authors:  Beatriz Gil; Jonathon Smith; Yong Tang; Peter Illes; Tobias Engel
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

Review 7.  Tribute to Prof. Geoffrey Burnstock: transition of purinergicsignaling to drug discovery.

Authors:  Kenneth A Jacobson
Journal:  Purinergic Signal       Date:  2020-08-14       Impact factor: 3.765

Review 8.  Alzheimer and Purinergic Signaling: Just a Matter of Inflammation?

Authors:  Stefania Merighi; Tino Emanuele Poloni; Anna Terrazzan; Eva Moretti; Stefania Gessi; Davide Ferrari
Journal:  Cells       Date:  2021-05-20       Impact factor: 6.600

Review 9.  P2X7R antagonists in chronic stress-based depression models: a review.

Authors:  Iven-Alex von Muecke-Heim; Clemens Ries; Lidia Urbina; Jan M Deussing
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-07-19       Impact factor: 5.270
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.